Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Eric Thomas Schmidt currently holds 21,251 shares of Allogene Therapeutics, Inc. (ALLO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric Thomas Schmidt has been a net seller of ALLO stock. They have purchased $0 and sold $3.1M worth of shares.
Eric Thomas Schmidt's most recent insider trade was on Jun 8, 2023, when they sold 5,200 shares at $0.00 per share.
Eric Thomas Schmidt serves as Executive at Allogene Therapeutics, Inc. (ALLO). They have executed 33 insider transactions totaling $3.1M over their tenure at the company.
Eric Thomas Schmidt holds the position of Executive at Allogene Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Eric Thomas Schmidt has shown a selling trading pattern, with $0 in total purchases and $3.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Eric Thomas Schmidt was on Feb 20, 2020, when they sold $6.0M worth of ALLO shares. This transaction involved 237,155 shares at $25.30 per share.
Eric Thomas Schmidt currently owns 21,251 shares of Allogene Therapeutics, Inc. (ALLO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Eric Thomas Schmidt's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Eric Thomas Schmidt has 33 Form 4 filings on record as an insider at Allogene Therapeutics, Inc..
Set alerts for Eric Thomas Schmidt and 40,000+ other insiders.